2024 annual financial data
Amylyx Pharmaceuticals 2024 Operating margin
Amylyx Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was -360.22%.
Operating income was -314,731,000 USD and net income was -301,743,000 USD.
Operating cash flow was -167,647,000 USD.
Get free Amylyx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 87,371,000 USD
- Operating income
- -314,731,000 USD
- Net income
- -301,743,000 USD
- Operating cash flow
- -167,647,000 USD